ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699095; 2) Community: the network communities that were significantly associated with the response to NSC 699095; 3) Molecule: the relationships between components within communities and NSC 699095; 4) MDR: the compounds that were significantly associated with the NSC 699095.

NSC Compound Enrichment Correlation
NSC 672140 Null 0.0129421834592789 0.26408558
NSC 686393 Null 0.0129421834592789 -0.082731722
NSC 710326 Null 0.012942183459279 -0.15547841
NSC 715407 Null 0.012942183459279 0.36440746
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.012942183459279 0.32865456
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.012942183459279 0.13789593
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.012942183459279 0.39726507
NSC 752346 Null 0.012942183459279 0.29321105
NSC 758670 TANNIC ACID 0.012942183459279 0.18023712
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0133012546828912 0.13154508
Total:75  Current:22    [First] [Prev] [Next] [Last]